PYRIMETHAMINE SULFADIAZINE VERSUS PYRIMETHAMINE CLINDAMYCIN FOR INDUCTION THERAPY OF TOXOPLASMIC ENCEPHALITIS IN AIDS PATIENTS

被引：0
|
作者：
ANTUNES, F [1 ]
CARVALHO, C [1 ]
BOTAS, J [1 ]
CALDEIRA, L [1 ]
DUARTE, N [1 ]
DOROANA, M [1 ]
TAVARES, L [1 ]
ARAUJO, FC [1 ]
机构：
[1] UNIV LISBON,HOSP ST MARIA,FAC MED,SERV DOENCAS INFECC,P-1600 LISBON,PORTUGAL
来源：
JOURNAL OF CHEMOTHERAPY | 1993年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：522 / 522
页数：1
相关论文
共 50 条
  • [21] RUSH DESENSITIZATION TO CLINDAMYCIN OF AIDS PATIENTS TREATED FOR TOXOPLASMIC ENCEPHALITIS
    MORLAT, P
    GOULLIN, B
    RAGNAUD, JM
    GIN, H
    DELAFAYE, C
    AUBERTIN, J
    MEDECINE ET MALADIES INFECTIEUSES, 1993, 23 (05): : 371 - 373
  • [22] Randomized Trial of Intravitreal Clindamycin and Dexamethasone versus Pyrimethamine, Sulfadiazine, and Prednisolone in Treatment of Ocular Toxoplasmosis
    Soheilian, Masoud
    Ramezani, Alireza
    Azimzadeh, Ahmad
    Sadoughi, Mohammad Mehdi
    Dehghan, Mohammad H.
    Shahghadami, Reza
    Yaseri, Mehdi
    Peyman, Gholam A.
    OPHTHALMOLOGY, 2011, 118 (01) : 134 - 141
  • [23] PYRIMETHAMINE SULFADIAZINE-RESISTANT CEREBRAL TOXOPLASMOSIS IN AIDS
    LANGMANN, P
    KLINKER, H
    RICHTER, E
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1995, 120 (21) : 780 - 780
  • [24] Dose-escalation, phase I/II study of azithromycin and pyrimethamine for the treatment of toxoplasmic encephalitis in AIDS
    Jacobson, JM
    Hafner, R
    Remington, J
    Farthing, C
    Holden-Wiltse, J
    Bosler, EM
    Harris, C
    Jayaweera, DT
    Roque, C
    Luft, BJ
    AIDS, 2001, 15 (05) : 583 - 589
  • [25] Drug monitoring of pyrimethamine during maintenance therapy of toxoplasmic encephalitis in patients with advanced HIV infection during HAART
    Langmann, P
    Zilly, M
    Schirmer, D
    Klinker, H
    MEDICAL SCIENCE MONITOR, 2004, 10 (05): : PI65 - PI69
  • [26] AN OPEN STUDY OF THE PYRIMETHAMINE-CLINDAMYCIN COMBINATION IN AIDS PATIENTS WITH BRAIN TOXOPLASMOSIS
    LEPORT, C
    BASTUJIGARIN, S
    PERRONNE, C
    SALMON, D
    MARCHE, C
    BRICAIRE, F
    VILDE, JL
    JOURNAL OF INFECTIOUS DISEASES, 1989, 160 (03): : 557 - 558
  • [27] Twice-weekly pyrimethamine-sulfadoxine effectively prevents Pneumocystis carinii pneumonia relapse and toxoplasmic encephalitis in patients with AIDS
    Schürmann, D
    Bergmann, F
    Albrecht, H
    Padberg, J
    Grünewald, T
    Behnsch, M
    Grobusch, M
    Vallée, M
    Wünsche, T
    Ruf, B
    Suttorp, N
    JOURNAL OF INFECTION, 2001, 42 (01) : 8 - 15
  • [28] Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 study
    Chirgwin, K
    Hafner, R
    Leport, C
    Remington, J
    Andersen, J
    Bosler, EM
    Roque, C
    Rajicic, N
    McAuliffe, V
    Morlat, P
    Jayaweera, DT
    Vilde, JL
    Luft, BJ
    CLINICAL INFECTIOUS DISEASES, 2002, 34 (09) : 1243 - 1250
  • [29] INTRAVENOUS CLINDAMYCIN (C) - AN ALTERNATIVE TREATMENT FOR AIDS PATIENTS WITH TOXOPLASMIC ENCEPHALITIS (TE)
    DANNEMANN, BR
    ISRAELSKI, DM
    REMINGTON, JS
    CLINICAL RESEARCH, 1988, 36 (01): : A189 - A189
  • [30] Toxoplasmic encephalitis relapse rates with pyrimethamine-based therapy: systematic review and meta-analysis
    Connolly, Mark P.
    Goodwin, Elizabeth
    Schey, Carina
    Zummo, Jacqueline
    PATHOGENS AND GLOBAL HEALTH, 2017, 111 (01) : 31 - 44
12345